HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guanine nucleotide regulation of dopamine receptor agonist affinity states in rat estradiol-induced pituitary tumors.

Abstract
We have investigated dopamine (DA) receptor agonist high- and low-affinity states in female rat estradiol-induced prolactin (PRL)-secreting pituitary tumors and intact pituitary tissue. Estradiol treatment increased the anterior pituitary weight 9-fold and plasma prolactin levels 74-fold and these measures are correlated (R = 0.745, n = 73, p less than 0.001). Competition for [3H]-spiperone binding to the DA receptor by apomorphine was compared in normal and adenomatous pituitary tissue. The inhibition constants (Ki) and the proportions of the two apomorphine sites are unchanged in tumors compared to intact pituitary tissue. Guanosine 5'-[beta-gamma-imino]triphosphate (Gpp(NH)p) causes complete conversion of the high into low affinity dopaminergic agonist site in normal pituitary and in tumors. These results suggest that rats with primary estradiol-induced pituitary tumors have normal and functional DA receptors.
AuthorsT Di Paolo, P Falardeau
JournalLife sciences (Life Sci) Vol. 41 Issue 9 Pg. 1149-53 (Aug 31 1987) ISSN: 0024-3205 [Print] Netherlands
PMID3613869 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Guanine Nucleotides
  • Receptors, Dopamine
  • Guanylyl Imidodiphosphate
  • Estradiol
  • Prolactin
Topics
  • Animals
  • Estradiol
  • Guanine Nucleotides (physiology)
  • Guanylyl Imidodiphosphate (pharmacology)
  • Organ Size (drug effects)
  • Pituitary Gland, Anterior (anatomy & histology)
  • Pituitary Neoplasms (chemically induced, physiopathology)
  • Prolactin (metabolism)
  • Rats
  • Receptors, Dopamine (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: